Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,668,506
+$1,458,719 QoQ
Shares Held
4,726
+3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#1,614
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. LLY ranks #3 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,668,506 | 4,726 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,209,787 | 4,577 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $5,014,457 | 4,666 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,990,490 | 5,230 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,914,020 | 5,021 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,986,667 | 4,827 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,486,612 | 3,221 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,671,995 | 3,016 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,691,694 | 2,973 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,553,264 | 3,282 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,914,892 | 3,285 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,808,516 | 3,367 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,691,610 | 3,607 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,218,110 | 3,547 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,375,558 | 3,760 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,198,011 | 3,705 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,210,999 | 3,735 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $994,276 | 3,472 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $946,053 | 3,425 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $746,753 | 3,232 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $747,546 | 3,257 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $581,383 | 3,112 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $518,001 | 3,068 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $343,258 | 2,319 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $378,599 | 2,306 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $320,304 | 2,309 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||